MCM
ANGO icon

Moore Capital Management’s AngioDynamics ANGO Stock Holding History

Moore Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
183,099
-12,404
-6% -$141K 0.04% 372
2026
Q1 		$2.22M Buy
195,503
+29,267
+18% +$317K 0.05% 266
2025
Q4 		$2.13M Sell
166,236
-71,728
-30% -$885K 0.03% 364
2025
Q3 		$2.66M Buy
237,964
+147,324
+163% +$1.42M 0.04% 324
2025
Q2 		$899K Buy
90,640
+634
+0.7% +$6.21K 0.01% 391
2025
Q1 		$845K Buy
+90,006
New +$946K 0.02% 329

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moore Capital Management's ANGO Position: Q2 2026 in Review

Moore Capital Management reduced its AngioDynamics (ANGO) stake by 6.3% in Q2 2026, selling an estimated $141K and leaving 183,099 shares worth $2.38M. The position accounts for 0.04% of the portfolio, ranked #372.

Moore Capital Management first reported a position in ANGO in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.66M in Q3 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Moore Capital Management held 183,099 shares of AngioDynamics worth $2.38M as of Q2 2026.
  • Moore Capital Management sold 12,404 AngioDynamics shares in Q2 2026, an estimated $141K.
  • AngioDynamics made up 0.04% of Moore Capital Management's portfolio in Q2 2026, its #372 holding.
  • Moore Capital Management first reported a position in AngioDynamics in Q1 2025 and has held it in 6 quarters since.
  • Moore Capital Management's AngioDynamics position peaked at $2.66M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.